Nat. Rev. Rheumatol. doi: /nrrheum

Slides:

Advertisements

Similar presentations

“CRISPR genome editing” Precise gene regulation/modification using the simple CRISPR/Cas9 system Thank you. Nucleeases will be used as a new tool that.

Advertisements

Genome Editing Katie Plummer.

Xiaole Shirley Liu STAT115, STAT215, BIO298, BIST520

Figure 1 Lymphocytes during the disease

Figure 3 Example of how a noncoding regulatory rheumatoid

Figure 3 Connexins in cartilage

Figure 1 Historical evolution of the clinical classification and

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 2 Representative MSI data obtained from human joints

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

CRISPR + CAS = Defensive or Immune System

Figure 1 Grip strength across the lifecourse

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Enthesitis versus synovitis

Nat. Rev. Rheumatol. doi: /nrrheum

CRISPR/Cas9 Clustered Regularly Interspaced Short Palindromic Repeats

Figure 1 Factors underlying metabolic alterations in osteoarthritis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Assays for detecting antidrug antibodies to TNF inhibitors

Figure 4 Simplified T cell and antigen presenting

Figure 1 Experimental design

Figure 2 Targeted versus untargeted metabolomics approaches

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Simplified EULAR and GRAPPA

Figure 2 Simplified EULAR and GRAPPA

Figure 4 Antinuclear antibodies and disease activity in SLE

Figure 3 Transcriptome studies performed in the target

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Shared genetic loci in systemic autoimmune diseases

Figure 1 Location of HLA variants known to be associated

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Strategies to achieve therapeutic inhibition of IL-1

Figure 1 Pharmacodynamics of methotrexate in RA

Figure 2 Cas9 targeting using crRNA (CRISPR

Figure 2 Overlap of associated loci among five rheumatic diseases

Figure 2 Interaction effects between heterozygous HLA‑DRB1

Genomics for Regional Development

Nat. Rev. Rheumatol. doi: /nrrheum

Work arrangements, productivity, and self-confidence at work as affected by RA. a For example: Stopped working altogether, moved from full-time to part-time.

Figure 3 Statistical approaches for the analysis of metabolomic data

Figure 3 Cell-surface markers for NP cell differentiation

Figure 5 The role of Ly6Chi and Ly6Clo monocytes

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Multi-hit model for autoimmune diseases

Figure 1 Simplified EULAR and GRAPPA

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Emerging hallmarks of T cells in rheumatoid arthritis

Figure 1 Adaptive immune system of bacteria and archaea

Figure 1 Biospecimen handling pipeline

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 The current model of the pathogenesis of SLE

Figure 8 HRQOL in individuals with RA

Figure 6 Metabolism of pterins

Figure 1 Principles for the diagnosis and management of osteoarthritis

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 A large number of genes are potentially associated with CIPN

Figure 2 Embryonic origins of tissue-resident macrophages

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Overall worldwide prevalence ranges for SLE

Mean differences with 95% CI between the Internal Family Systems (IFS) intervention group and the education group in study outcomes at baseline and 3,

Figure 1 Patterns of joint and organ involvement in rheumatic disease

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 The role of macrophages in RA

Malignancy-related events over time for all-bari-RA analysis set (IR).

Nat. Rev. Rheumatol. doi: /nrrheum

Presentation transcript:

Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.80 Figure 1 Timeline of the major advances in rheumatoid arthritis genetics research Figure 1 | Timeline of the major advances in rheumatoid arthritis genetics research. Advances in genetic research relevant to rheumatoid arthritis since 1950. AMD, age-related macular degeneration; CHi‑C, capture Hi‑C; CRISPR, clustered regularly interspaced short palindromic repeats; GWAS, genome wide association study; RA, rheumatoid arthritis. Eyre, S. et al. (2017) The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.80